These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 10642959)
1. Neonatal lung function in very immature infants with and without RDS. Kavvadia V; Greenough A; Itakura Y; Dimitriou G J Perinat Med; 1999; 27(5):382-7. PubMed ID: 10642959 [TBL] [Abstract][Full Text] [Related]
2. Functional residual capacity and static compliance during the first year in preterm infants treated with surfactant. de Winter JP; Merth IT; Brand R; Quanjer PH Am J Perinatol; 2000; 17(7):377-84. PubMed ID: 12141525 [TBL] [Abstract][Full Text] [Related]
3. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants]. de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193 [TBL] [Abstract][Full Text] [Related]
4. Repeat surfactant therapy for postsurfactant slump. Katz LA; Klein JM J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122 [TBL] [Abstract][Full Text] [Related]
5. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation. Kattwinkel J; Bloom BT; Delmore P; Davis CL; Farrell E; Friss H; Jung AL; King K; Mueller D Pediatrics; 1993 Jul; 92(1):90-8. PubMed ID: 8516091 [TBL] [Abstract][Full Text] [Related]
6. Combined effects of antenatal corticosteroids and surfactant supplementation on the outcome of very low birth weight infants. Modanlou HD; Beharry K; Padilla G; Iriye B J Perinatol; 1996; 16(6):422-8; quiz 429-30. PubMed ID: 8979178 [TBL] [Abstract][Full Text] [Related]
7. Neonatal respiratory distress syndrome as a function of gestational age and an assay for surfactant-to-albumin ratio. McElrath TF; Colon I; Hecht J; Tanasijevic MJ; Norwitz ER Obstet Gynecol; 2004 Mar; 103(3):463-8. PubMed ID: 14990407 [TBL] [Abstract][Full Text] [Related]
8. Changes in lung volume and ventilation during surfactant treatment in ventilated preterm infants. Miedema M; de Jongh FH; Frerichs I; van Veenendaal MB; van Kaam AH Am J Respir Crit Care Med; 2011 Jul; 184(1):100-5. PubMed ID: 21493733 [TBL] [Abstract][Full Text] [Related]
9. Onset of mechanical ventilation is associated with rapid activation of circulating phagocytes in preterm infants. Turunen R; Nupponen I; Siitonen S; Repo H; Andersson S Pediatrics; 2006 Feb; 117(2):448-54. PubMed ID: 16452365 [TBL] [Abstract][Full Text] [Related]
10. Functional residual capacity and compliance of the respiratory system after surfactant treatment in premature infants with severe respiratory distress syndrome. Dinger J; Töpfer A; Schaller P; Schwarze R Eur J Pediatr; 2002 Sep; 161(9):485-90. PubMed ID: 12200607 [TBL] [Abstract][Full Text] [Related]
11. Decreased respiratory compliance in infants less than or equal to 32 weeks' gestation, delivered more than 7 days after antenatal steroid therapy. McEvoy C; Schilling D; Spitale P; Peters D; O'Malley J; Durand M Pediatrics; 2008 May; 121(5):e1032-8. PubMed ID: 18450845 [TBL] [Abstract][Full Text] [Related]
12. Effects of surfactant treatment on gas-exchange and clinical course in near-term newborns with RDS. Golombek SG; Truog WE J Perinat Med; 2000; 28(6):436-42. PubMed ID: 11155428 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the effects of surfactant replacement therapy in neonatal respiratory distress syndrome. Ghaemi S; Mohamadymasodi M; Kelishadi R Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):188-90. PubMed ID: 19292953 [TBL] [Abstract][Full Text] [Related]
14. [Importance of pre- and perinatal risk factors in respiratory distress syndrome of premature infants. A logical regression analysis of 1100 cases]. Harms K; Herting E; Kron M; Schill M; Schiffmann H Z Geburtshilfe Neonatol; 1997; 201(6):258-62. PubMed ID: 9491546 [TBL] [Abstract][Full Text] [Related]
15. [Administration of exogenous surfactant in premature very low birth weight infants with RDS]. Iarŭkova N; Vakrilova L; Slŭncheva B; Dancheva S; Popivanova A; Emilova Z; Dimitrov A; Chernev T; Nikolov A Akush Ginekol (Sofiia); 1999; 38(1):23-6. PubMed ID: 11965714 [TBL] [Abstract][Full Text] [Related]
17. The effect of exogenous surfactant replacement therapy on lung function. Yüksel B; Greenough A Turk J Pediatr; 1993; 35(1):53-7. PubMed ID: 8236518 [TBL] [Abstract][Full Text] [Related]
18. Effect of positive end expiratory pressure on functional residual capacity and compliance in surfactant-treated preterm infants. Dinger J; Töpfer A; Schaller P; Schwarze R J Perinat Med; 2001; 29(2):137-43. PubMed ID: 11344672 [TBL] [Abstract][Full Text] [Related]
19. Comparisons of mortality and pre-discharge respiratory outcomes in small-for-gestational-age and appropriate-for-gestational-age premature infants. Sharma P; McKay K; Rosenkrantz TS; Hussain N BMC Pediatr; 2004 Jun; 4():9. PubMed ID: 15186501 [TBL] [Abstract][Full Text] [Related]
20. Surfactant treatment in premature infants with Respiratory Distress Syndrome in Curaçao. Verhagen AA; Keli SO; van der Meulen GN; Wiersma H; Arias M; Angelista IR; Muskiet FD West Indian Med J; 2001 Jun; 50(2):117-22. PubMed ID: 11677907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]